Hmmm - the FDA have issued a warning today to stop using "the Innova SARS-CoV-2 Antigen Rapid Qualitative Test" because it's not regulated for use in the US, and they have concerns that "performance of the test has not been adequately established, presenting a risk to health."
https://www.fda.gov/medical-devices/safety-communications/stop-using-innova-sars-cov-2-antigen-rapid-qualitative-test-fda-safety-communication
They mention "labeling distributed with certain configurations of the test includes performance claims that did not accurately reflect the performance estimates observed during the clinical studies of the tests. ". But thejr warning seems to apply to all tests, not just these batches, because the test is not approved full stop, not just because some batches had misleading information leaflets.
So it's not entirely clear, but the FDA release appears to concern all Innova SARS-CoV-2 Antigen Rapid Qualitative Tests, not just the previously recalled batches?